Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology
D Seoane-Mato, C Sánchez-Piedra… - … Clínica (English Edition), 2019 - Elsevier
Aims To describe the methodology of the EPISER 2016 (study of the prevalence of
rheumatic diseases in adult population in Spain), as well its strengths and limitations. The …
rheumatic diseases in adult population in Spain), as well its strengths and limitations. The …
[HTML][HTML] The prevalence of rheumatoid arthritis in Spain
L Silva-Fernández, C Macía-Villa, D Seoane-Mato… - Scientific Reports, 2020 - nature.com
Rheumatoid arthritis (RA) prevalence is believed to be around 1% worldwide, although it
varies considerably among different populations. The aim of EPISER2016 study was to …
varies considerably among different populations. The aim of EPISER2016 study was to …
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
V Torrente-Segarra, TC Salman-Monte… - Seminars in Arthritis and …, 2020 - Elsevier
Objective To assess the incidence of serious infection (SI) and associated factors in a large
juvenile-onset systemic lupus erythematosus (jSLE) retrospective cohort. Methods All …
juvenile-onset systemic lupus erythematosus (jSLE) retrospective cohort. Methods All …
Prevalencia de enfermedades reumáticas en población adulta en España (estudio EPISER 2016). Objetivos y metodología
D Seoane-Mato, C Sánchez-Piedra… - Reumatología …, 2019 - Elsevier
Objetivos Describir la metodología del estudio de prevalencia de las enfermedades
reumáticas en la población adulta en España, EPISER 2016, así como sus fortalezas y …
reumáticas en la población adulta en España, EPISER 2016, así como sus fortalezas y …
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
JL Martín-Varillas, L Sanchez-Bilbao, V Calvo-Río… - RMD open, 2022 - rmdopen.bmj.com
Objectives To evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to
immune-mediated inflammatory diseases (IMID). Methods Multicentre study of CZP-treated …
immune-mediated inflammatory diseases (IMID). Methods Multicentre study of CZP-treated …
245 Associations between patient acceptable symptom stateand three domains of the disease in SLE: a cross-sectional study of 1,364 patients from the spanish …
TRV Rodriguez, IR Figueroa, VDC Perez… - 2019 - lupus.bmj.com
Background In a large cohort of systemic lupus erythematosus (SLE) patients, to evaluate
the association between a Patient Acceptable Symptom State (PASS) and three different …
the association between a Patient Acceptable Symptom State (PASS) and three different …
Valoración del riesgo de fractura en población general en España mediante el algoritmo FRAX®: Estudio EPISER2016
C Gómez-Vaquero, D Fábregas-Canales… - Medicina Clínica, 2020 - Elsevier
Objetivos Analizar el riesgo de fractura calculado por FRAX® y la frecuencia de alto riesgo
de fractura en la población general en España. Métodos EPISER2016 es un estudio …
de fractura en la población general en España. Métodos EPISER2016 es un estudio …
[CITATION][C] 245 Associations between patient acceptable symptom stateand three domains of the disease in SLE: a cross-sectional study of 1,364 patients from the …
TR Vazquez Rodriguez, IR Figueroa, VDC Perez… - 2019 - Lupus Foundation of America
[CITATION][C] Lupus Impact Tracker Validation in a Large European Spanish Lupus Registry Cohort
DR Azizoddin, Í Rúa Figueroa, H Devilliers… - 2018
[CITATION][C] Lupus Impact Tracker Responds to Changes in Low Disease Activity and Remission Outcomes in a Large Spanish Lupus Registry Cohort
H Devilliers, Í Rúa Figueroa, DR Azizoddin… - 2018